Quantitative ultrasound and risk factor enquiry as predictors of postmenopausal osteoporosis: comparative study in primary care.

1 Lave J, Schulberg H. Integrating cost-effectiveness analyses within clinical trials of treatment for major depression in primary-care practice. In: Miller N, Magruder K, eds. Cost-effectiveness of psychotherapy: a guide for practitioners, researchers and policy makers. New York: Oxford University Press, 1999;75-84. 2 Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000;321:1362-3. 3 Johnston K, Buxton M, Jones D, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials.Health Technol Assess 1999;3(6). 4 King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, et al. Randomised controlled trial of non-directive counselling, cognitivebehaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.Health Technol Assess 2000;4(19). 5 Friedli K, King M, Lloyd M. The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. Br J Gen Pract 2000;50:276-83. 6 Harvey I, Nelson S, Lyons R, Unwin C, Monaghan S, Peters T. A randomized controlled trial and economic evaluation of counselling in primary care. Br J Gen Pract 1998;48:1043-8. 7 Simpson S, Corney R, Fitzgerald P, Beecham J. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression.Health Technol Assess 2000;4(36). 8 Stewart L, Clarke M, Cochrane Working Group on meta-analysis using individual patient data. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1995;14:2057-79. 9 Gotzsche P. Why we need a broad perspective on meta-analysis. BMJ 2000;321:585-6. 10 Sutton A, Abrams K, Jones D, Sheldon T, Song F. Systematic reviews of trials and other studies.Health Technol Assess 1998;2(19). 11 Efron B, Tibshirani R.An introduction to the bootstrap. New York: Chapman and Hall, 1993. 12 Van Hout B, Al M, Gordon G, Rutten F. Costs, effects, and C/E ratios alongside a clinical trial.Health Econ 1994;3:309-13. 13 Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, eds. Economic evaluation in health care:merging theory and practice. London: Gaskell, 2001;172-214. 14 Speirs R, Jewell J. One counsellor, two practices: report of a pilot scheme in Cambridgeshire. Br J Gen Pract 1995;45:31-3. 15 Briggs A, Clark T, Wolstenholme J, Clarke P. Missing . . . presumed at random: cost-analysis of incomplete data. Health Econ 2003;12: 377-92. 16 Kaltenthaler E, Shackley P, Stevens P, Beverley C, Parry G, Chilcott J. A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess 2002;6(22).